Becton Dickinson & Co (BDX) company profile

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Its operations encompass five primary business segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. The company provides solutions such as infusion systems, vascular access products, specimen collection devices, diagnostic instruments, cell analysis tools, and surgical and urological implants. BD serves a broad customer base that includes hospitals, clinics, healthcare professionals, life science researchers, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, retail pharmacies, and consumers.

The company operates on a worldwide scale, maintaining international business operations organized across Europe, the Middle East, and Africa (EMEA), Greater Asia, Latin America, and Canada. BD employs approximately 72,000 associates across 61 countries and maintains manufacturing facilities in the United States as well as 17 other countries, including Bosnia and Herzegovina, Brazil, Canada, China, France, Germany, India, Ireland, Japan, Mexico, and Singapore. The company maintains its corporate executive offices in Franklin Lakes, New Jersey.

Summary of the business section of Becton Dickinson's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“We strive to continually invest in our associates with the goal of being an employer of choice for our approximately 72,000 associates located in 61 countries (as of September 30, 2025).”